MedPath

The Effect of a Blue Light Filtering IOL

Not Applicable
Completed
Conditions
on the Incidence of Cystoid Macular Edema
After Cataract Surgery
to Compare the Effect of Two Types of IOLs
Interventions
Procedure: intraocular lens implantation
Registration Number
NCT00571831
Lead Sponsor
Showa University
Brief Summary

To compare the effect on blood retinal barrier disruption 3 and 12 months after implantation of either a blue light filtering intraocular lens(blue-filtering IOL) or an ultraviolet light filtering intraocular lens(UV-filtering IOL).

Detailed Description

The following parameters were measured for evaluation of blood retinal barrier disruption.

* the incidence of macular leakage by fluorescence angiography (FA)

* the mean fluorescein concentration in the vitreous by fluorophotometry (VFP)

* the thickness of the macula by optical coherence tomography (OCT)

Results

* the incidence fo macular leakage decreased significantly from 24%(3 months) to 5% (12 months) in the blue-filtering IOL group (P\<0.05), and was significantly lower compared with the UV-filtering IOL group at 12 months.

* the VFP significantly decreased in both group from 3 to 12 months.

* the OCT decreased from 175 (3 months) to 166 um (12 months) in the blue- filtering IOL group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • cataract patients
  • All eligible for intraocular lens implantation
Exclusion Criteria
  • Patients had undergone an intraocular operation
  • Patients had hypertensive retinopathy
  • Patients had diabetic retinopathy
  • Patients had ange-related macular degeneration
  • no observable fundus
  • The cataract operation was more than 30 minutes in duration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
letterintraocular lens implantationa blue-filtering IOL an UV-filtering IOL
Primary Outcome Measures
NameTimeMethod
To measure FA, VEP and OCT.At 3 and 12 months after IOL implantation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Showa University Hospital

🇯🇵

Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath